Exploring stage I non-small-cell lung cancer: Development of a prognostic model predicting 5-year survival after surgical resection

European Journal of Cardio-thoracic Surgery

Volumn 47, Issue 6, 2014, Pages 1037-1043

  Guerrera, Francesco ^a   Errico, Luca ^b   Evangelista, Andrea ^c   Filosso, Pier Luigi ^a   Ruffini, Enrico ^a   Lisi, Elena ^b   Bora, Giulia ^a   Asteggiano, Elena ^b   Olivetti, Stefania ^a   Lausi, Paolo ^a   Ardissone, Francesco ^b   Oliaro, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Early stage; Non small cell lung cancer; NSCLC; Prognostic factors; Staging; Surgery; Survival

Indexed keywords

CARBON MONOXIDE;

AGE; AGED; ARTICLE; CALIBRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; COMORBIDITY; DISEASE SEVERITY; ELECTROCORTICOGRAPHY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG DIFFUSION CAPACITY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MORBIDITY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING HABIT; SQUAMOUS CELL LUNG CARCINOMA; SURVIVAL TIME; TUMOR INVASION; CARCINOMA, NON-SMALL-CELL LUNG; ITALY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MORTALITY; PROGNOSIS; RISK;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK;

EID: 84930459808     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu410     Document Type: Article

References (24)

1. Vallières E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-59.
2. Sculier JP, Chansky K, Crowley J, Van Meerbeeck J, Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol 2008;3:457-66.
3. Iverson C, Christiansen S, Flanagin A, eds. AMA Manual of Style, 10th ed. New York, NY: Oxford University Press; 2009; Section 2 Chap 11.10.1. http:// www.amamanualofstyle.com/view/10.1093/jama/9780195176339.001.0001/ med-780195176339-div2-350?rskey=5g3yYp&result=1 (30 April 2012, date last accessed).
4. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92.
5. Chang MY, Mentzer SJ, Colson YL, Linden PA, Jaklitsch MT, Lipsitz SR et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007;134:850-6.
6. Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008;3:46-52.
7. Sigel K, Bonomi M, Packer S, Wisnivesky J. Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 2009;16: 1912-7.
8. Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008;26:54-9.
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Cancer Incidence, Mortality and Prevalence Worldwide in 2008. Lyon, France: International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2008v1.2. http://globocan.iarc.fr (13 August 2012, date last accessed).
10. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA 2004;291:1763-8.
11. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801.
12. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-72.
13. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97: 339-46.
14. Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol 2009;100:703-7.
15. Ferguson MK, Dignam JJ, Siddique J, Vigneswaran WT, Celauro AD. Diffusing capacity predicts long-term survival after lung resection for cancer. Eur J Cardiothorac Surg 2012;41:e81-6.
16. Brunelli A, Salati M, Refai M, Xiumé F, Berardi R, Mazzanti P et al. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer. J Thorac Cardiovasc Surg 2013;146:385-90.e1-2.
17. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-9.
18. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662-70.
19. Wu Y, Huang ZF,Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
20. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e278S-313S.
21. Hasebe T, Sasaki S, Imoto S, Ochiai A. Histological characteristics of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast: a prospective study. Hum Pathol 2004;35:298-308.
22. Poncelet AJ, Cornet J, Coulon C, Collard P, Noirhomme P, Weynand B. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma. Eur J Cardiothorac Surg 2008;33:799-804.
23. Kobayashi N, Toyooka S, Soh J, Ichimura K, Yanai H, Suehisa H et al. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol 2007;2:808-12.
24. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-85.